Pharmacokinetics of selected stilbenes: Rhapontigenin, piceatannol and pinosylvin in rats

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 11, 2006, Pages 1443-1450

  Roupe, Kathryn A ^a   Yáñez, Jaime A ^a   Teng, Xiao Wei ^a   Davies, Neal M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PICEATANNOL; PINOSYLVIN; RESVERATROL; RHAPONTIGENIN; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG URINE LEVEL; JUGULAR VEIN; MALE; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; MASS SPECTROMETRY; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; TISSUE DISTRIBUTION;

EID: 33751232933     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.11.0004     Document Type: Article

References (30)

1. Asensi, M., Medina, I., Ortega, A., Carrertero, J., Bano, M. C., Obrador, E. Estrela, J. M. (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 33: 387-398
2. Bavaresco, L. (2003) Role of viticultural factors on stilbene concentrations of grapes and wine. Drugs Exp. Clin. Res. 29: 181-187
3. Bavaresco, L., Fregoni, C., Cantu, E., Trevisan, M. (1999) Stilbene compounds: from the grapevine to wine. Drugs Exp. Clin. Res. 25: 57-63
4. Chen, G., Shan, W., Wu, Y., Ren, L., Dong, J., Ji, Z. (2005) Synthesis and anti-inflammatory activity of resveratrol analogs. Chem. Pharm. Bull. (Tokyo) 54: 1587-1590
5. Davies, B., Morris, T. (1993) Physiological parameters in laboratory animals and humans. Pharm. Res. 10: 1093-1095
6. Fremont, L. (2000) Biological effects of resveratrol. Life Sci. 66: 663-673
7. Goldberg, D. A., Yan, J., Soleas, G. J. (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36: 79-87
8. Jeandet, P., Bessis, R., Sbaghi, M., Meunier, P., Trollat, P. (1995) Production of phytoalexin resveratrol by grapes in response to botryis attack under natural conditions. J. Phytopathol. 143: 135-139
9. Juan, M. E., Buenafuente, J., Casals, I., Planas, J. M. (2002) Plasmatic levels of trans-resveratrol in rats. Food Res. Int. 35: 195-199
10. Kodan, A., Kuroda, H., Sakai, F. (2002) A stilbene synthase from Japanese red pine (Pinus densiflora): implications for phytoalexin accumulation and down-regulation of flavonoid biosynthesis. Proc. Natl Acad. Sci. USA 99: 3335-3339
11. Larrosa, M., Tomas-Barberan, F. A., Espin, J. C. (2004) The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. Eur. J. Nutr. 43: 275-284
12. Maboudian-Esfahani, M., Brocks, D. R. (1999) Pharmacokinetics of ethopropazine in the rat after oral and intravenous administration. Biopharm Drug Dispos. 20: 159-163
13. Marier, J. F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J. P., Ducharme, M. P. (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 302: 369-373
14. Park, E. J., Min, H. Y., Ahn, Y. H., Bae, C. M., Pyee, J. H., Lee, S. K. (2004) Synthesis and inhibitory effects of pinosylvin derivatives on prostaglandin E2 production in lipopolysaccharide-induced mouse macrophage cells. Bioorg. Med. Chem. Lett. 14: 5895-5898
15. Pettit, G. R., Grealish, M. P., Jung, M. K., Hamel, E., Pettit, R. K., Chapuis, J. C., Schmidt, J. M. (2002) Antineoplastic agents. 465. Structural modification of resveratrol: sodium rescerastatin phosphate. J. Med. Chem. 6: 2534-2542
16. Roberti, M., Pizzirani, D., Simoni, D., Rondanin, R., Baruchello, R., Bonora, C., Buscemi, F., Grimaudo, S., Tolomeo, M. (2003) Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J. Med. Chem. 46: 3546-3554
17. Roupe, K. A. (2005) Pharmacometrics of selected stilbenes: piceatannol, pinosylvin and rhapontigenin. Doctoral Thesis, Washington State University, Pullman, WA, USA
18. Roupe, K. A., Teng, X. W., Fu, X., Meadows, G. G., Davies, N. M. (2004) Determination of piceatannol in rat plasma and liver microsomes: pharmacokinetics and phase I and II biotransformation. Biomed. Chromatogr. 18: 486-491
19. Roupe, K. A., Halls, S., Davies, N. M. (2005a) Determination and assay validation of pinosylvin in rat plasma: application to drug metabolism and pharmacokinetics. J. Pharm. Biomed. Anal. 38: 148-154
20. Roupe, K. A., Helms, G. L., Halls, S. C., Yáñez, J. A., Davies, N. M. (2005b) Enzymatic synthesis and HPLC analysis of rhapontigenin: applications to drug metabolism, pharmacokinetics and anti-cancer activity. J. Pharm. Pharm. Sci. 8: 374-386
21. Roupe, K. A., Fukuda, C., Halls, S., Yáñez, J. A., Davies, N. M. (2005c) Pinosylvin: method of analysis, anti-cancer activity and metabolism. AAPS J. 7 (Suppl. 2): T3261
22. Roupe, K. A., Helms, G., Halls, S., Yáñez, J. A., Davies, N. M. (2005d) Enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer activity. AAPS J. 7 (Suppl. 2): T3265
23. Roupe, K. A., Fukuda, C., Halls, S., Teng, X. W., Davies, N. M. (2005e) Anti-cancer activity, pharmacokinetics, and metabolism of piceatannol in vitro and in vivo. AAPS J. 7 (Suppl 2): T3263
24. Roupe, K. A., Remsberg, C., Yanez, J. A., Davies, N. M. (2006) Pharmacometrics of stilbenes: seguing towards the clinic. Curr. Clin. Pharmacol. 1, 81-101
25. Sale, S., Verschoyle, R. D., Boocock, D., Jones, D. J. L., Wilsher, N., Ruparelia, K. C., Potter, G. A., Farmer, P. B., Steard, W. P., Gescher, A. J. (2004) Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Br. J. Cancer 90: 736-744
26. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Walle, U. K. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32: 1377-1382
27. Wang, D., Hang, T., Wu, C., Liu, W. (2005) Identification of the major metabolites of resveratrol in rat urine by HPLC-MS-MS. J. Chromatogr. B. 829: 97-106
28. Wenzel, E., Somoza, V. (2005) Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 49: 472-481
29. Yao, Q., Hou, S. X., He, W. L., Feng, J. L., Wang, X. C., Fei, H. X., Chen, Z. H. (2006) Zhongguo Shong Yao Za Zhi 31: 205-208
30. Zhang, W., Oya, S., Kung, M. P., Hou, C., Maier, D. L., Kung, H. F. (2005) F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. Nucl. Med. Biol. 32: 799-809